MLICM
ATRC icon

Metropolitan Life Insurance Company (MetLife)’s AtriCure ATRC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,475
Closed -$75.3K – 204
2024
Q1 		$75.3K Sell
2,475
-205
-8% -$6.87K ﹤0.01% 1201
2023
Q4 		$95.6K Hold
2,680
– – ﹤0.01% 1109
2023
Q3 		$117K Buy
2,680
+135
+5% +$6.59K 0.01% 925
2023
Q2 		$126K Buy
2,545
+111
+5% +$5.12K 0.01% 901
2023
Q1 		$101K Sell
2,434
-318
-12% -$13.2K 0.01% 986
2022
Q4 		$122K Hold
2,752
– – 0.01% 955
2022
Q3 		$108K Hold
2,752
– – 0.01% 974
2022
Q2 		$112K Hold
2,752
– – ﹤0.01% 991
2022
Q1 		$181K Sell
2,752
-8,758
-76% -$568K 0.01% 866
2021
Q4 		$800K Sell
11,510
-650
-5% -$47.2K 0.01% 1129
2021
Q3 		$846K Hold
12,160
– – 0.01% 1088
2021
Q2 		$965K Sell
12,160
-101
-0.8% -$7.34K 0.01% 1035
2021
Q1 		$803K Sell
12,261
-538
-4% -$33.1K 0.01% 1107
2020
Q4 		$713K Hold
12,799
– – 0.01% 1121
2020
Q3 		$511K Buy
12,799
+1,041
+9% +$44.1K 0.01% 1205
2020
Q2 		$529K Hold
11,758
– – 0.01% 1160
2020
Q1 		$395K Sell
11,758
-1,774
-13% -$63.8K 0.01% 1189
2019
Q4 		$440K Hold
13,532
– – 0.01% 1408
2019
Q3 		$337K Buy
13,532
+1,837
+16% +$52.4K 0.01% 1533
2019
Q2 		$349K Hold
11,695
– – 0.01% 1522
2019
Q1 		$313K Hold
11,695
– – 0.01% 1602
2018
Q4 		$358K Buy
11,695
+401
+4% +$12.5K 0.01% 1428
2018
Q3 		$396K Hold
11,294
– – 0.01% 1530
2018
Q2 		$306K Hold
11,294
– – 0.01% 1643
2018
Q1 		$232K Buy
11,294
+513
+5% +$9.26K ﹤0.01% 1804
2017
Q4 		$197K Sell
10,781
-12,940
-55% -$256K ﹤0.01% 1918
2017
Q3 		$531K Hold
23,721
– – ﹤0.01% 1654
2017
Q2 		$575K Hold
23,721
– – ﹤0.01% 1587
2017
Q1 		$454K Hold
23,721
– – ﹤0.01% 1712
2016
Q4 		$464K Hold
23,721
– – ﹤0.01% 1787
2016
Q3 		$375K Hold
23,721
– – ﹤0.01% 1896
2016
Q2 		$335K Buy
23,721
+3,374
+17% +$51.4K ﹤0.01% 1949
2016
Q1 		$342K Buy
20,347
+661
+3% +$11.6K ﹤0.01% 1815
2015
Q4 		$442K Hold
19,686
– – ﹤0.01% 1699
2015
Q3 		$431K Sell
19,686
-3,525
-15% -$88.1K ﹤0.01% 1733
2015
Q2 		$572K Sell
23,211
-1,318
-5% -$29.4K ﹤0.01% 1652
2015
Q1 		$503K Hold
24,529
– – ﹤0.01% 1556
2014
Q4 		$490K Sell
24,529
-998
-4% -$17.1K ﹤0.01% 1776
2014
Q3 		$376K Sell
25,527
-2
-0% -$32 ﹤0.01% 1909
2014
Q2 		$469K Buy
25,529
+8,569
+51% +$143K ﹤0.01% 1871
2014
Q1 		$319K Hold
16,960
– – ﹤0.01% 2122
2013
Q4 		$317K Hold
16,960
– – ﹤0.01% 2146
2013
Q3 		$186K Hold
16,960
– – ﹤0.01% 2475
2013
Q2 		$161K Buy
+16,960
New +$148K ﹤0.01% 2501

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ATRC Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 2,475 shares — an estimated $75.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ATRC in Q2 2013 and held it in 44 quarters. The position peaked at $965K in Q2 2021. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,475 AtriCure shares in Q2 2024, an estimated $75.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in AtriCure in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s AtriCure position peaked at $965K in Q2 2021.
  • 197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.